genomics revolution. This genomics revolution is not exempt from challenges, in part amplified by lack of standards (ethical, legal, and technological), slow translation of knowledge to the clinic, and unequal access of personal genome benefits for all.As the vast majority of reference data in public databases continue to be of European ancestries, existing health disparities between rich and poor are likely to continue. In parallel, access to directto-consumer personal genetic testing continues to increase the public's appetite for genotyping and ancestry testing, resulting in greater number of enquiries with clinicians and public healthcare systems. This has left many medical professionals unprepared and unable to harness the wave of patient-focused healthcare and demand for data sharing -data sharing which is crucial for establishing better, more precise tools for diagnosis and treatment. However, sharing also opens the door for privacy concerns as secure access of genome data and metadata cannot always be guaranteed. Increased legal protection and institutional support are likely to keep promoting positive impact for diverse participation.On April 11-12 2019, we helped organise the First Personal Genomes Conference at the Wellcome Genome Campus, Hinxton, UK, to discuss issues around personal genomic data access, sharing and interpretation (Rubin and Glusman, 2019) In conclusion, we observe that although general access to personal genome data is becoming more widespread, the benefits of such advances are being deployed unevenly. Tools are being implemented that help facilitate the interpretation of personal genomic data and their increased, more secure sharing. We see these advances being undertaken both by academic and industry sectors. But a number of ethical challenges persist, including how to return data to participants in different regions of the world, or how to access direct-to-consumer services and raw data for personal genome analysis, which still remain biased depending on the individual's local jurisdiction. It is our wish to raise awareness about these hurdles and to bring all stakeholders involved into fruitful discussions to promote greater access to the benefits of personal genomics for all.
6 Authors
- MJ
Michael J. S. Beauvais
Centre of Genomics and Policy, Faculty of Medicine, McGill University, Canada
- AM
Adrian M. Thorogood
ELIXIR-LU, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg
- MJ
Michael J. Szego
Centre for Clinical Ethics, Unity Health, Canada
- KS
Karine Sénécal
Independent Researcher, Canada
- MH
Ma'n H. Zawati
Centre of Genomics and Policy, Faculty of Medicine, McGill University, Canada
- BM
Bartha Maria Knoppers
Centre of Genomics and Policy, Faculty of Medicine, McGill University, Canada
7,761 views
8 citations
9 Authors
- SM
Sanja Mehandziska
Zan Mitrev Clinic, Macedonia
- AS
Aleksandra Stajkovska
Bio Engineering LLC, Macedonia
- MS
Margarita Stavrevska
Zan Mitrev Clinic, Macedonia
- KJ
Kristina Jakovleva
Zan Mitrev Clinic, Macedonia
- MJ
Marija Janevska
Bio Engineering LLC, Macedonia
- RR
Rodney Rosalia
Zan Mitrev Clinic, Macedonia
- IK
Ivan Kungulovski
Bio Engineering LLC, Macedonia
- ZM
Zan Mitrev
Zan Mitrev Clinic, Macedonia
- GK
Goran Kungulovski
Bio Engineering LLC, Macedonia
8,061 views
6 citations
10 Authors
- JA
José Afonso Guerra-Assunção
Infection and Immunity, University College London, United Kingdom
- LC
Lucia Conde
Bill Lyons Informatics Centre, UCL Cancer Institute, University College London, United Kingdom
- IM
Ismail Moghul
Medical Genomics, UCL Cancer Institute, University College London, United Kingdom
- AP
Amy P. Webster
Medical Genomics, UCL Cancer Institute, University College London, United Kingdom
- SE
Simone Ecker
Medical Genomics, UCL Cancer Institute, University College London, United Kingdom
- OC
Olga Chervova
Medical Genomics, UCL Cancer Institute, University College London, United Kingdom
- CC
Christina Chatzipantsiou
Lifebit, United Kingdom
- PP
Pablo P. Prieto
Lifebit, United Kingdom
- SB
Stephan Beck
Medical Genomics, UCL Cancer Institute, University College London, United Kingdom
- JH
Javier Herrero
Bill Lyons Informatics Centre, UCL Cancer Institute, University College London, United Kingdom
6,501 views
6 citations
5 Authors
- MC
Manuel Corpas
Cambridge Precision Medicine Limited, ideaSpace, University of Cambridge Biomedical Innovation Hub, United Kingdom
- KM
Karyn Megy
Cambridge Precision Medicine Limited, ideaSpace, University of Cambridge Biomedical Innovation Hub, United Kingdom
- VM
Vanisha Mistry
Fabric Genomics, United States
- AM
Antonio Metastasio
Cambridge Precision Medicine Limited, ideaSpace, University of Cambridge Biomedical Innovation Hub, United Kingdom
- EL
Edmund Lehmann
Cambridge Precision Medicine Limited, ideaSpace, University of Cambridge Biomedical Innovation Hub, United Kingdom
6,809 views
3 citations
6 Authors
- LF
Lasse Folkersen
Institute of Biological Psychiatry, Mental Health Centre Sankt Hans, Denmark
- OP
Oliver Pain
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, United Kingdom
- AI
Andrés Ingason
Institute of Biological Psychiatry, Mental Health Centre Sankt Hans, Denmark
- TW
Thomas Werge
Institute of Biological Psychiatry, Mental Health Centre Sankt Hans, Denmark
- CM
Cathryn M. Lewis
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, United Kingdom
- JA
Jehannine Austin
Department of Psychiatry, University of British Columbia, Canada
3 Authors
- SE
Susan E. Wallace
Department of Health Sciences, University of Leicester, United Kingdom
- EK
Emily Kirby
Centre of Genomics and Policy, McGill University, Canada
- BM
Bartha Maria Knoppers
Centre of Genomics and Policy, McGill University, Canada
3,894 views
15 citations

